THE Therapeutic Goods
Administration has approved the
Australian registration of Illumina’s
MiSeqDx system, which is an
instrument offering a variety of
assays and kits enabling clinical
laboratories to “create and deploy
next-generation sequencing-based
molecular diagnostic testing”.
The instrument is now cleared
for clinical use in the US, Canada,
Argentina, Europe, South Korea,
Singapore, Thailand and the
Philippines as well as Australia.The above article was sent to subscribers in Pharmacy Daily's issue from 27 May 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 May 16
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.